CANTON, Mass. (AP) _ Organogenesis Holdings Inc. (ORGO) on Wednesday reported earnings of $215,000 in its third quarter.

On a per-share basis, the Canton, Massachusetts-based company said it had profit of less than 1 cent. Earnings, adjusted for non-recurring costs, were 4 cents per share.

The regenerative medicine company posted revenue of $116.9 million in the period.

Organogenesis expects full-year revenue in the range of $448 million to $465 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News